The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
about
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situr84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity inductionSelection and characterization of high affinity VEGFR1 antibodies from a novel human binary code scFv phage library.VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer CellsVEGF targets the tumour cell.MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosisThe VEGF family in cancer and antibody-based strategies for their inhibition.Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies.Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer.PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.Vascular endothelial growth factor receptor-2 in breast cancer.Targeted inhibition of VEGF receptor 2: an update on ramucirumab.Ontogenomic study of the relationship between number of gene splice variants and GO categorization.MYC in breast tumor progressionRoles for growth factors in cancer progression.Vascular endothelial growth factor receptor-1 activation promotes migration and invasion of breast cancer cells through epithelial-mesenchymal transition.Radioactive ¹²⁵I seed inhibits the cell growth, migration, and invasion of nasopharyngeal carcinoma by triggering DNA damage and inactivating VEGF-A/ERK signaling.Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells.Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacyVascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumorsOverexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions.VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomyNotch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth.Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic TherapiesOverexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptorsTargeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy.Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy.Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase.A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallateCompartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice.Functional significance of VEGFR-2 on ovarian cancer cells.VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinomaVEGFR and type-V RTK activation and signalingNew potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatmentVascular endothelial growth factor receptor-1 expression in breast cancer and its correlation to vascular endothelial growth factor aVEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells.Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
P2860
Q21195234-18DCAA59-0E70-46A4-9A4D-596A3F8B8F14Q27321768-51DAAA71-E18D-44B4-8009-A5731D8501DDQ27330448-79C05297-1358-49CB-A49F-31E5EF326493Q28607569-8E2920FC-BE90-43ED-B165-08FC2A1B559BQ33573324-411B2818-3373-4182-A372-8F08AFAB35D4Q33713359-7B5A03E2-4429-468F-82E4-F47AC89A6259Q33733437-594C3AB1-D4F6-4764-B9D5-60812D80E6F5Q33771212-BD8AE7D6-42E8-4BB7-B340-2E9C4B9DBDD5Q33780689-72827CA0-8798-40E7-A32F-53B47AF2B269Q33826204-1D73D5D9-26F8-4C60-B824-BDE072583740Q33912620-436853BC-5A01-4864-9358-AD15368BC0C7Q34040956-D0CD80A5-78C7-46B0-96E6-72F762BC2146Q34046959-C5C40C75-825B-4DC2-A59D-715FFAA4CEB2Q34524915-E55037C4-743D-404C-8BAB-3ACF2C720692Q34705858-83BE1DF6-4A4A-44E3-B20D-7BBD99969DE9Q34775622-2DAE451E-025E-4DF9-8D46-E60F0B2C007AQ34989673-19330366-A860-432F-8EAF-AABFA48A21C2Q35082888-3B4E7C89-1677-4A37-84DF-0DCAE321AB75Q35105257-7148FE4C-5E15-4F29-B951-F168215A8EB8Q35110068-4F07E492-BD94-48D4-BAE4-A5AF1E4D5B8AQ35534079-715261E8-A4CD-438C-8D11-4E56363FE195Q35585704-FE4FFA30-382F-4CA3-87A3-702DE0929F57Q35963167-78415661-78CD-48C6-A46A-FCF9D4441150Q36137701-E083ACC9-A420-4FD3-9C2A-CAC3CB629098Q36247439-7FD20EC9-C2B9-411B-ABA4-77C111DDDE10Q36395933-5463208A-6871-4294-AC45-4DD3CCDEB2A1Q36468606-04416356-5B8B-4A04-A0AC-EA478E9B50B6Q36640234-039F53B6-1C27-4CC3-A3F3-97ACE271D474Q36661727-A263833C-C6C9-4D40-8C34-6FBD47C072A3Q36846579-2F37213D-6E2F-4B8F-ABAB-ABE4B3BCE23AQ36884836-6278B7AE-CB55-4EE8-A7A4-61B857A9F0ECQ36935966-7C0177B2-100B-4523-9B52-9BA31D95C5D4Q37054876-C0D1D321-6684-4FF3-BED7-490EE62C33D1Q37156401-C7ABA518-8019-4142-8F9A-D83A64F0F237Q37158442-912D40DF-E29A-4557-8969-323915C245BCQ37197494-4309B535-85E1-483D-971A-F1123A80BBB9Q37330349-175DFA4A-7C42-4E46-AF1C-EB6AD607344CQ37422370-1CFF83A6-9233-4665-8C70-4119147E07ECQ37672753-1906A624-59CC-4001-8186-C8F8B60136C3Q37687310-9728ACEB-4A97-444E-9624-12EDAB0768BE
P2860
The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The vascular endothelial growt ...... val of human breast carcinoma.
@en
type
label
The vascular endothelial growt ...... val of human breast carcinoma.
@en
prefLabel
The vascular endothelial growt ...... val of human breast carcinoma.
@en
P2093
P2860
P356
P1476
The vascular endothelial growt ...... val of human breast carcinoma.
@en
P2093
Andrea T Hooper
Daniel J Hicklin
Larry Witte
Peter Bohlen
Shahin Rafii
Zhaojing Zhong
P2860
P304
P356
10.1002/IJC.21865
P577
2006-10-01T00:00:00Z